We found ways to shorten the turnaround time for diagnosing babies with HIV

January 17, 2018 by Jónas Oddur Jónasson, The Conversation
Exploring ways to improve the turnaround times for HIV tests on babies. Credit: Shutterstock

They say timing is everything. And in sub-Saharan Africa, where roughly a third of untreated HIV infected babies die before they reach the age of one, a timely diagnosis is everything.

According to the latest UNAIDS data, 150 000 children are infected with HIV in sub-Saharan Africa, annually. Due to the high number of children dying, diagnosing babies with HIV as early as possible is critical.

Public health officials have been grappling with this for many years. How can they reduce the time it takes to get newborns' blood samples to the diagnostic lab and the test results back? This matters because it determines how soon babies can start medical treatment. The average time in sub-Saharan Africa often range from one to three months.

In general, shorter turnaround times can be achieved by improving the clinic-to-lab supply chain. This can happen through increasing the number of vehicles equipped to transport samples, hiring enough drivers, training enough medical personnel, buying the right type of diagnostic equipment, and improving communication systems.

African countries like Malawi and Nigeria have done this, with impressive results.

But as we show in our new study improving the day-to-day operations of clinic-to-lab supply chains is simply not enough. Sometimes the opportunities lie in the structure of the supply chain itself.

We came to this conclusion after evaluating the early infant diagnosis network in Mozambique. It's one of many sub-Saharan African nations struggling to improve its turnaround time for HIV testing.

We examined tens of thousands of cases in Mozambique right down to the original time stamps on samples and the return dates of test results. Then we developed a tool to streamline this system. We found that some simple changes could improve the turnaround time and increase the number of infants starting treatment.

An inefficient system

One of the biggest barriers to faster test turnaround times in Mozambique has to do with the network structure of laboratories and clinics. There are about 400 clinics in the country. These are assigned to laboratories based on governmental administrative districts. But these boundaries are drawn for political reasons instead of reasons.

As a result one administrative district may be densely populated while another is sparsely populated. And this means that the workload at the various diagnostic laboratories differs according to the size of their surrounding populations.

If too many clinics send their samples to the same lab, they become congested and results are delayed. But if too few clinics send their samples to a given lab, the technicians have to wait longer to gather enough samples to justify conducting tests. This is because it costs just as much to test 100 samples as it does one sample – and the materials are expensive.

Changing the system

For our study we developed two models which captured the operational, medical, and behavioural factors affecting an early infant diagnosis network's effectiveness.

In the first model we re-assigned clinics to labs to maximize the number of infants who start treatment, by minimizing the turnaround time of results.

It showed us two important things. Firstly, a relatively minor modification reassigning some clinics to different labs could decrease the average sample turnaround time by 11% compared with the current system.

Secondly, this increased the number of infected infants starting treatment by about 4%.

But we took our modelling one step further. In our second model we wanted to determine if relocating the existing diagnostic machinery between labs could have an even larger public health impact.

What we found was that consolidating all diagnostic capacity in one centralised lab is optimal. Based on our study we predict that consolidation could decrease the average turnaround times by an estimated 22% and increase the number of infected babies initiating treatment by 7%.

This result has implications, as consolidating diagnostic laboratories has been a much-debated issue in the field of public health in sub-Saharan Africa.

The bigger picture

Improving turnaround times between the diagnostic lab and the clinic and speeding up the initiation date for HIV positive babies to start treatment boils down to using operations management to improve global health.

By shaving precious days, weeks and even months off diagnostic turnaround times, infants infected with HIV are able to get treatment quicker.

Whether it's reassigning clinics among the existing labs, or optimally reallocating the diagnostic capacity to a centralised lab, improvements need to be made because timing truly is everything.

Explore further: Rapid diagnostic test helps distinguish between severe and uncomplicated malaria in Africa

Related Stories

Rapid diagnostic test helps distinguish between severe and uncomplicated malaria in Africa

August 24, 2017
Malaria is a leading cause of death for children living in Sub-Saharan Africa. Many children in rural areas seek care at local community health clinics, but these clinics lack reliable tests to distinguish severe and uncomplicated ...

Second HIV test helps prevent incorrect HIV diagnosis in infants

November 21, 2017
Confirmatory HIV testing can substantially reduce the number of infants in South Africa who may be falsely diagnosed as HIV-infected and started on unneeded treatment, according to a new study published this week in PLOS ...

Point-of-care CD4 testing is economically feasible for HIV care in resource-limited areas

September 16, 2014
A new point-of-care test to measure CD4 T-cells, the prime indicator of HIV disease progression, can expedite the process leading from HIV diagnosis to antiretroviral therapy (ART) and improve clinical outcomes. Now a study ...

Lab constraints delay Zika test results

October 10, 2016
Houston-based Legacy Community Health Services , a federally qualified health center, is trying hard to fight the Zika virus. It's screening pregnant women and following federal guidelines to test people at risk.

Engineers enter fight against AIDS in Africa

April 10, 2012
(AP) -- Getting AIDS test results from labs to remote villages once took weeks in Mozambique, with the information sent by courier along the impoverished country's terrible roads. The delay could mean death.

Recommended for you

Researchers find new way to defeat HIV latency

March 8, 2018
HIV, the virus that causes AIDS, has a secret life. Though anti-retroviral therapy can reduce its numbers, the virus can hide and avoid both treatments and the body's immune response.

Broadly neutralizing antibody treatment may target viral reservoir in monkeys

March 5, 2018
After receiving a course of antiretroviral therapy for their HIV-like infection, approximately half of a group of monkeys infused with a broadly neutralizing antibody to HIV combined with an immune stimulatory compound suppressed ...

HIV begins to yield secrets of how it hides in cells

March 2, 2018
UC San Francisco scientists have uncovered new mechanisms by which HIV hides in infected cells, resting in a latent state that evades the body's immune system and prevents antiviral drugs from flushing it out.

HIV exports viral protein in cellular packages

February 15, 2018
HIV may be able to affect cells it can't directly infect by packaging a key protein within the host's cellular mail and sending it out into the body, according to a new study out of a University of North Carolina Lineberger ...

Can gene therapy be harnessed to fight the AIDS virus?

February 13, 2018
For more than a decade, the strongest AIDS drugs could not fully control Matt Chappell's HIV infection. Now his body controls it by itself, and researchers are trying to perfect the gene editing that made this possible.

Big data methods applied to the fitness landscape of the HIV envelope protein

February 7, 2018
Despite significant advances in medicine, there is still no effective vaccine for the human immunodeficiency virus (HIV), although recent hope has emerged through the discovery of antibodies capable of neutralizing diverse ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.